Get started
Author

Louis-Hippolyte Minvielle Moncla

Observed name: Moncla, Louis-Hippolyte Minvielle
ORCID: 0000-0002-0257-2518
Observed ORCID: 0000-0002-0257-2518
OpenAlex ID: A5071792021
Calcific aortic valve disease: mechanisms, prevention and treatment
2023 · Louis-Hippolyte Minvielle Moncla, Mewen Briend, et al. · Nature Reviews Cardiology · 317
Mendelian randomization of circulating proteome identifies actionable targets in heart failure
2022 · Louis-Hippolyte Minvielle Moncla, Samuel Mathieu, et al. · BMC Genomics · 23
PDF
Mendelian randomization reveals interactions of the blood proteome and immunome in mitral valve prolapse
2024 · Louis-Hippolyte Minvielle Moncla, Mewen Briend, et al. · Communications Medicine · 5
Connectome and regulatory hubs of CAGE highly active enhancers
2023 · Mewen Briend, Anne Rufiange, et al. · Scientific Reports · 3
PDF
Efficient molecular mendelian randomization screens with LaScaMolMR.jl
2024 · Samuel Mathieu, Louis-Hippolyte Minvielle Moncla, et al. · medRxiv · 1
Blood proteome-wide Mendelian randomization reveals molecular pleiotropy in coronary artery disease
2026 · Louis-Hippolyte Minvielle Moncla, Samuel Mathieu, et al. · Atherosclerosis
Integrative Analysis of the Blood Proteome by Mendelian Randomization Reveals Regulatory Networks in Calcific Aortic Valve Disease
2023 · Mewen Briend, Louis-Hippolyte Minvielle Moncla, et al. · medRxiv
PDF
Mendelian Randomization of Circulating Proteome Identifies Actionable Targets in Heart Failure
2022 · Louis-Hippolyte Minvielle Moncla, Samuel Mathieu, et al. · Research Square
PDF
Additional file 2 of Mendelian randomization of circulating proteome identifies actionable targets in heart failure
2022 · Moncla, Louis-Hippolyte Minvielle, Mathieu, Samuel, et al. · Figshare
Works count: 9
Citation count: 349
H-index: 3
I10-index: 2
Year
Topic
Type